![Ryan Barrett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ryan Barrett
Président chez
GABA Therapeutics, Inc.
Fortune : 702 449 $ au 31/05/2026
Profil
Ryan Barrett is currently Chairman at GABA Therapeutics, Inc., Director at Perception Neuroscience, Inc., Director at Recognify Life Sciences, Inc., and will be Chief Legal & Business Officer at Atai Beckley, Inc. starting in 2025.
Former roles include Director at IntelGenx Technologies Corp.
from 2023 to 2024, VP & Senior Corporate Counsel at OvaScience, Inc., Vice President- Corporate Development at Vertero Therapeutics, Inc., and Secretary & Vice President-Corporate Development at Atai Beckley NV.
Education includes undergraduate studies at Trinity College (Connecticut) and graduate studies at Case Western Reserve University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,04% | 01/10/2025 | 155 066 ( 0,04% ) | 702 449 $ | 31/05/2026 |
Postes actifs de Ryan Barrett
| Sociétés | Poste | Début |
|---|---|---|
Perception Neuroscience, Inc.
 Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Develops therapies in neuropsychiatry industry | Directeur/Membre du Conseil | - |
Recognify Life Sciences, Inc.
 Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for cognitive impairment associated with schizophrenia | Directeur/Membre du Conseil | - |
GABA Therapeutics, Inc.
 GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Président | - |
Anciens postes connus de Ryan Barrett
| Sociétés | Poste | Fin |
|---|---|---|
| INTELGENX TECHNOLOGIES CORP. | Directeur/Membre du Conseil | 17/05/2024 |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of new fertility treatment options for women | Corporate Officer/Principal | - |
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotherapeutics | Corporate Officer/Principal | - |
ATAI Life Sciences NV
 ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Conseiller Juridique Général | - |
Formation de Ryan Barrett
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Trinity College (Connecticut)
 Trinity College (Connecticut) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IntelGenx Technologies Corp.
 IntelGenx Technologies Corp. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops and manufactures oral film therapeutics | Health Technology |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of new fertility treatment options for women | Health Technology |
Case Western Reserve University School of Law
 Case Western Reserve University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotherapeutics | Health Technology |
Perception Neuroscience, Inc.
Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Develops therapies in neuropsychiatry industry | Health Services |
GABA Therapeutics, Inc.
GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Recognify Life Sciences, Inc.
Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for cognitive impairment associated with schizophrenia | Commercial Services |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
